12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJan 2 16:05 ET

Earnings Scheduled For December 19, 2024

BenzingaDec 19, 2024 03:32 ET

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18, 2024 08:00 ET

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published In The Journal Of Clinical Endocrinology And Metabolism

BenzingaDec 2, 2024 09:06 ET

MBX Biosciences Announces The Completion Of The Last Subject's Last Visit In Its Phase 1 Single And Multiple Ascending Dose Trial Of MBX 1416, The Company's Long-Acting Glucagon-Like Peptide 1 Receptor Antagonist In Development For The Treatment Of...

BenzingaNov 18, 2024 08:19 ET

Express News | Mbx Biosciences : Look Forward to Sharing Full-Topline Results of Mbx 1416 Program in Early January 2025

ReutersNov 18, 2024 08:03 ET